New guidelines employ a team approach to autism diagnosis and care

Improving diagnosis and treatment for individuals with autism has been the focus of a growing body of research. New information from these studies led the American Academy of Child and Adolescent Psychiatry to revise key parameters for evaluating and treating autism. Researchers led by Yale Child Study Center director Dr. Fred Volkmar have published the new practice parameters.
‘Early diagnosis of children with autism spectrum disorders means treatments will be introduced that lead to more positive outcomes for children,’ said Volkmar the Irving B. Harris Professor of Psychiatry, Pediatrics, and Psychology at the Yale School of Medicine.
According to the parameters, clinicians should routinely look for symptoms of autism spectrum disorder in young children undergoing developmental assessments, and in all psychiatric evaluations. If significant symptoms are detected, clinicians should then co-ordinate a careful medical, psychological, and communication evaluation. These evaluations should differentiate between autism and a variety of developmental and other disorders, as well as intellectual and behavioural disabilities.
‘Our goal was advocacy for individuals with autism and their families, and to ensure that services are co-ordinated across clinical care,’ said Volkmar. ‘Our field is changing rapidly, and these parameters are meant to promote effective care and move professional medical methods closer to current practices.’
Volkmar and his co-authors reviewed abstracts from 9,481 research articles on autism that were published between 1991 and 2013. They then fully studied 186 of those articles based on their quality and ability to be applied more generally.
‘Treatment should involve a team approach,’ said Volkmar, who notes that under these treatment parameters, psychiatrists will closely co-ordinate diagnosis and treatment with teachers, behavioural psychologists, and speech and language pathologists, and look for commonly occurring conditions.
A key addition to the new parameters is a focus on how clinicians should address the use of non-traditional therapies, like chelation and secretin. Clinicians are urged to ask families if they are using alternative/complementary treatments and to discuss the therapies